Status of drug development for the prevention and treatment of osteoporosis.
about
From disease to treatment: from rare skeletal disorders to treatments for osteoporosisPu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro.A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase.Osteoimmunology and Beyond.Appropriate models for novel osteoporosis drug discovery and future perspectives.Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.Treatment of osteoporosis in children with glucocorticoid-treated diseases
P2860
Q26764854-36FE0ABA-EEB7-46D7-B104-AABBFABD2F0DQ33742422-E8569152-D91E-4CB5-8AB2-8C3C6ECCB3D2Q36687909-9BE23789-D25C-4C8C-8D5C-F8DDB830B81DQ37548012-4901885C-CA4E-4952-A58A-3AC8CE4E676DQ38570326-717D1CFE-CCB4-4DEE-803D-2764A3A9C0C6Q40682785-9DF58845-8922-4BC4-AE06-7498DFDC323AQ58327145-7E1BE157-9A27-4310-A895-3B93A7647E32
P2860
Status of drug development for the prevention and treatment of osteoporosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Status of drug development for the prevention and treatment of osteoporosis.
@en
type
label
Status of drug development for the prevention and treatment of osteoporosis.
@en
prefLabel
Status of drug development for the prevention and treatment of osteoporosis.
@en
P2860
P50
P1476
Status of drug development for the prevention and treatment of osteoporosis.
@en
P2860
P304
P356
10.1517/17460441.2014.884067
P407
P577
2014-02-04T00:00:00Z